Zura Bio (ZURA) Notes Payables (2021 - 2022)
Zura Bio (ZURA) posted quarterly Notes Payables of $7.8 million for Q4 2022, up 269955.71% year-over-year from N/an in Q4 2021, and up 2485.5% quarter-over-quarter from $299981.0 in Q3 2022.
Zura Bio (ZURA) Notes Payables (2021 - 2022) Analysis & Trends
Zura Bio's Notes Payables history runs 2 years deep, the most recent figure standing at $7.8 million for Q4 2022.
- In Q4 2022, Notes Payables rose 269955.71% year-over-year to $7.8 million; the TTM figure through Dec 2022 stood at $7.8 million (up 269955.71% YoY), while the FY2022 annual figure was $7.8 million, up 269955.71% from the prior year.
- Notes Payables for Q4 2022 stood at $7.8 million, up from $299981.0 in the prior quarter.
- The five-year high for Notes Payables was $7.8 million in Q4 2022, with the low at $2872.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Zura Bio | 706.30 Mn | 706.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 7.76 Mn |
| Sep 30, 2022 | 299,981.00 |
| Jun 30, 2022 | 102,893.00 |
| Dec 31, 2021 | 2,872.00 |